JP2015083580A5 - - Google Patents

Download PDF

Info

Publication number
JP2015083580A5
JP2015083580A5 JP2014245645A JP2014245645A JP2015083580A5 JP 2015083580 A5 JP2015083580 A5 JP 2015083580A5 JP 2014245645 A JP2014245645 A JP 2014245645A JP 2014245645 A JP2014245645 A JP 2014245645A JP 2015083580 A5 JP2015083580 A5 JP 2015083580A5
Authority
JP
Japan
Prior art keywords
constipation
pharmaceutical
medicament
functional
glucopyranosyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014245645A
Other languages
English (en)
Japanese (ja)
Other versions
JP6105546B2 (ja
JP2015083580A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014245645A priority Critical patent/JP6105546B2/ja
Priority claimed from JP2014245645A external-priority patent/JP6105546B2/ja
Publication of JP2015083580A publication Critical patent/JP2015083580A/ja
Publication of JP2015083580A5 publication Critical patent/JP2015083580A5/ja
Application granted granted Critical
Publication of JP6105546B2 publication Critical patent/JP6105546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014245645A 2012-05-07 2014-12-04 ピラゾール誘導体及びその医薬用途 Active JP6105546B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014245645A JP6105546B2 (ja) 2012-05-07 2014-12-04 ピラゾール誘導体及びその医薬用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012105847 2012-05-07
JP2012105847 2012-05-07
JP2014245645A JP6105546B2 (ja) 2012-05-07 2014-12-04 ピラゾール誘導体及びその医薬用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014514708A Division JP5663699B2 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2015083580A JP2015083580A (ja) 2015-04-30
JP2015083580A5 true JP2015083580A5 (cg-RX-API-DMAC7.html) 2016-06-16
JP6105546B2 JP6105546B2 (ja) 2017-03-29

Family

ID=49550709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014514708A Active JP5663699B2 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途
JP2014245645A Active JP6105546B2 (ja) 2012-05-07 2014-12-04 ピラゾール誘導体及びその医薬用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014514708A Active JP5663699B2 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Country Status (15)

Country Link
US (2) US9273085B2 (cg-RX-API-DMAC7.html)
EP (1) EP2848254B1 (cg-RX-API-DMAC7.html)
JP (2) JP5663699B2 (cg-RX-API-DMAC7.html)
KR (1) KR101868991B1 (cg-RX-API-DMAC7.html)
CN (1) CN104284665B (cg-RX-API-DMAC7.html)
AU (1) AU2013258566B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014027841B1 (cg-RX-API-DMAC7.html)
CA (1) CA2872002C (cg-RX-API-DMAC7.html)
DK (1) DK2848254T3 (cg-RX-API-DMAC7.html)
ES (1) ES2601127T3 (cg-RX-API-DMAC7.html)
MX (1) MX359988B (cg-RX-API-DMAC7.html)
PL (1) PL2848254T3 (cg-RX-API-DMAC7.html)
PT (1) PT2848254T (cg-RX-API-DMAC7.html)
RU (1) RU2602739C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013168671A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201800453T1 (it) 2010-11-04 2018-11-09 Albireo Ab Inibitori di ibat per il trattamento delle epatopatie
RU2602739C2 (ru) * 2012-05-07 2016-11-20 Киссеи Фармасьютикал Ко., Лтд. Производное пиразола и его применение в медицинских целях
CA2899834C (en) 2013-02-04 2020-09-01 Taisho Pharmaceutical Co., Ltd. Use of 4-isopropylphenyl glucitol compounds in the treatment of constipation
JP6751020B2 (ja) 2014-06-25 2020-09-02 Eaファーマ株式会社 固形製剤及びその着色防止又は着色低減方法
CN106573033A (zh) * 2014-06-25 2017-04-19 Ea制药株式会社 固体制剂及其稳定化方法
US11596644B2 (en) 2018-03-28 2023-03-07 Avolynt Method for treating post-prandial hypoglycemia
TW202015699A (zh) 2018-06-05 2020-05-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
FI3810581T3 (fi) 2018-06-20 2025-02-28 Albireo Ab Odeviksibaatin kiteiset modifikaatiot
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
ES2937153T3 (es) 2019-02-06 2023-03-24 Albireo Ab Compuestos de benzotiadiazepinas y su uso como moduladores de ácidos biliares
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CN114761018B (zh) 2019-12-04 2025-12-02 阿尔比里奥公司 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
KR20220109450A (ko) 2019-12-04 2022-08-04 알비레오 에이비 벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의 이의 용도
ES2973355T3 (es) 2019-12-04 2024-06-19 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
CA3158276A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
CA3186857A1 (en) 2020-08-03 2022-02-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症(pfic)を処置するためのオデビキシバット
CN116583504A (zh) 2020-12-04 2023-08-11 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
EP2046799B1 (en) * 2006-04-26 2017-07-19 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
EP2228378B1 (en) * 2007-12-27 2015-09-09 Kissei Pharmaceutical Co., Ltd. Monosebacate of pyrazole derivative
CN102007138B (zh) 2008-04-16 2014-05-21 橘生药品工业株式会社 吡唑衍生物的半富马酸盐
WO2011002001A1 (ja) * 2009-07-01 2011-01-06 キッセイ薬品工業株式会社 ピラゾール誘導体とビグアナイド薬との組み合わせ医薬
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
RU2602739C2 (ru) * 2012-05-07 2016-11-20 Киссеи Фармасьютикал Ко., Лтд. Производное пиразола и его применение в медицинских целях

Similar Documents

Publication Publication Date Title
JP2015083580A5 (cg-RX-API-DMAC7.html)
ES2601127T3 (es) Derivado de pirazol y su uso con fines médicos
JP2015523407A5 (cg-RX-API-DMAC7.html)
JP2015057451A5 (cg-RX-API-DMAC7.html)
NZ780890A (en) Pharmaceutical compositions comprising meloxicam
JP2016106150A5 (cg-RX-API-DMAC7.html)
JP2012193216A5 (cg-RX-API-DMAC7.html)
BR112014012815A8 (pt) derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
CN109982699A (zh) 一种mor激动剂与kor激动剂的药物组合物及其用途
CN111836807A (zh) 氧杂螺环类化合物及其制备方法和用途
JP2014198723A5 (cg-RX-API-DMAC7.html)
JP2017014206A5 (cg-RX-API-DMAC7.html)
RU2014141893A (ru) Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
JP2012517449A5 (cg-RX-API-DMAC7.html)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
JP2013166781A5 (cg-RX-API-DMAC7.html)
JP2018521007A5 (cg-RX-API-DMAC7.html)
JP2019218379A5 (cg-RX-API-DMAC7.html)
JP2018531273A5 (cg-RX-API-DMAC7.html)
JP2016540000A5 (cg-RX-API-DMAC7.html)
RU2018126158A (ru) Применение триацетил-3-гидроксифениладенозина для получения фармацевтического лекарственного средства для предупреждения или лечения неалкогольной жировой болезни печени
JP2016538288A5 (cg-RX-API-DMAC7.html)
JP2013032308A5 (cg-RX-API-DMAC7.html)
JP2016540799A5 (cg-RX-API-DMAC7.html)
JP2017530142A5 (cg-RX-API-DMAC7.html)